Search
+
    SEARCHED FOR:

    KARNATAKA MEDICAL COUNCIL

    Election Day 2026 results so far: Abdul El-Sayed vs Mike Rogers in Michigan Senate race; who is Democrat's wife Sarah Jukaku?

    Election Day 2026 results so far: Michigan's closely watched 2026 Senate race pits Democrat Abdul El-Sayed against Republican Mike Rogers, with both candidates competing for a crucial seat. Most polls predict that Abdul El-Sayed might win. As voters head to the polls, here's what to know about El-Sayed's career, political background and wife, psychiatrist Sarah Jukaku.

    Right question for a bearish market: Not ‘will it fall’, but ‘is the business falling’? 5 large-caps with upside potential of up to 29%

    The best large companies are the ones FPIs own the most. So, when they decide to sell, it is precisely these high-quality stocks that see the heaviest selling. That is one of the reasons why large-cap stocks have been under pressure of late.

    These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 20%

    In times like these, the market will have its green and red days. What matters, however, is not the colour of a single day, but the things underneath it: The central bank, the fund flows, and, above all, corporate earnings. Watch those, stay patient, and forget the daily noise.

    QDENGA dengue vaccine to hit India market in 2027; Dr Reddy’s to sell it

    India's first approved dengue vaccine, QDENGA, will launch in the private market by mid-2027. Dr Reddy's Laboratories will distribute and promote the vaccine for individuals aged four to sixty. Takeda will retain rights for public market distribution as a future objective. QDENGA is a two-dose vaccine designed to protect against all four dengue virus serotypes. Dengue cases have significantly increased in India over the past two decades.

    Ayurveda eyes global growth as research, innovation reshape traditional system

    Ayurveda is gaining global relevance through research and innovation. Growing interest in holistic healthcare creates new international opportunities for this system. India's Ayush market has seen significant economic growth in recent years. The government promotes Ayush-based medical travel and introduced a dedicated visa. Ayurveda's future international success depends on evidence and standardized practices.

    The Employment Paradox: Why skilling one crore in AI will not create one crore jobs

    India has spent four decades proving that education does not, by itself, create work. Kerala is the evidence. We are now about to test whether training does, and the answer will be decided not by the mission but by whether anyone has built the job at the end of it.

    The Economic Times
    BACK TO TOP